Difficulty: Medium
Average Score: 87%
Practice
Following is an antagonist of ganglion type nicotinic receptors
Correct answer
C
Rationale
The correct answer is C) Trimethaphan. Trimethaphan is an antagonist of ganglion type nicotinic receptors. Ganglionic blockers like Trimethaphan act on nicotinic receptors in autonomic ganglia, blocking transmission in both sympathetic and parasympathetic ganglia. This results in decreased sympathetic and parasympathetic tone, leading to effects such as reduced heart rate and blood pressure.
Option A, Tubocurarine, is a neuromuscular blocking agent that acts at the neuromuscular junction, not at ganglionic nicotinic receptors. Option B, ╬▒-bungarotoxin, is a neurotoxin found in snake venom that binds irreversibly to nicotinic acetylcholine receptors at neuromuscular junctions, not ganglionic receptors.
Educational context: Understanding the mechanisms of action of drugs that target the peripheral nervous system is crucial in pharmacology. Knowing the specific receptors targeted by each drug helps in predicting their effects and potential side effects. It is important for healthcare professionals to be able to differentiate between drugs affecting different types of nicotinic receptors for safe and effective patient care.
Option A, Tubocurarine, is a neuromuscular blocking agent that acts at the neuromuscular junction, not at ganglionic nicotinic receptors. Option B, ╬▒-bungarotoxin, is a neurotoxin found in snake venom that binds irreversibly to nicotinic acetylcholine receptors at neuromuscular junctions, not ganglionic receptors.
Educational context: Understanding the mechanisms of action of drugs that target the peripheral nervous system is crucial in pharmacology. Knowing the specific receptors targeted by each drug helps in predicting their effects and potential side effects. It is important for healthcare professionals to be able to differentiate between drugs affecting different types of nicotinic receptors for safe and effective patient care.